Standard BioTools Inc. (LAB) IV/HV History
Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.
Standard BioTools Inc. (LAB) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $394.3M, listed on NASDAQ, employing roughly 814 people, carrying a beta of 1.31 to the broader market. Standard BioTools Inc. Led by Michael Egholm, public since 2011-02-10.
Snapshot as of May 13, 2026.
- Spot Price
- $1.00
- ATM IV
- 117.1%
- HV 20-Day
- 57.2%
- HV 60-Day
- 48.0%
- IV Rank
- 21.4%
- IV Percentile
- 52.4%
As of May 13, 2026, Standard BioTools Inc. (LAB) ATM implied volatility is 117.1%. 20-day realized volatility is 57.2%, producing an IV-HV spread of +59.9 vol points. Options are pricing in more volatility than the stock has recently delivered, the volatility risk premium. IV rank is 21.4%.
How LAB iv/hv history Data Feeds Strategy Selection
Strategy selection on Standard BioTools Inc. options does not derive from any single metric in isolation. The iv/hv history view above sits inside a broader read: ATM IV currently sits at 117.1% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the iv/hv history data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
Learn how implied vs realized volatility is reported and how to read the data →
Frequently asked LAB iv/hv history questions
- Is LAB options pricing rich or cheap right now?
- As of May 13, 2026, Standard BioTools Inc. (LAB) ATM IV is 117.1% against 20-day realized volatility of 57.2%. IV rank is 21.4%. LAB options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 59.9 vol points.
- What is the LAB variance risk premium?
- The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. LAB is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.
- What does LAB IV rank mean for strategy selection?
- IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. LAB's current rank of 21.4% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.